Yeah, if you look back to the preso 18months ago, credo has some very nice intercepts, but no follow up since.... seems starnge
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025